Yıl: 2021 Cilt: 22 Sayı: 1 Sayfa Aralığı: 37 - 41 Metin Dili: İngilizce DOI: 10.4274/jtgga.galenos.2020.2020.0153 İndeks Tarihi: 06-05-2021

Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou

Öz:
Objective: The primary aim of this study was to evaluate the factors affecting parametrial involvement in cervical cancer patients with tumor size ≤4 cm and selection of the low-risk patient group based on long-term oncologic outcomes.Material and Methods: Cervical cancer patients operated in the gynecologic oncology division between 2007 and 2013 were retrospectively evaluated. One-hundred and sixty-eight patients with tumor size ≤4 cm were identified. Of these, 159 (86.8%) underwent radical hysterectomy plus pelvic-para-aortic lymphadenectomy and nine (13.2%) underwent fertility-sparing surgery [radical trachelectomy (n=7); large conization (n=2)]. Factors affecting parametrial invasion, including lymphovascular space invasion (LVSI), deep stromal invasion (DSI), lymph node metastases, and tumor size, were evaluated. Statistical analyses were performed using SPSS 23.0 (IBM Corp., Armonk, NY, USA).Results: Median age was 49.5 years and median tumor size was 2.5 cm (0.45-4 cm). In both univariate and multivariate analyses, the risk of parametrial involvement was increased with LVSI with a hazard ratio (HR) of 3.45 [95% confidence interval (CI): 1.1-10.8] and DSI with a HR of 4.1 (95% CI: 1.18-14.8), while tumor size of ≤2 cm was only significant in univariate analyses. Furthermore, 26 early-stage patients were identified with low-risk factors and they had no parametrial involvement, lymph node metastases, recurrence, or death from disease over 77 months.Conclusion: Parametrial involvement in low-risk cervical cancer is very rare and less radical procedures may be safe in these patients. (J Turk Ger Gynecol Assoc 2021; 22: 37-41)
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
  • 2. Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol 2011; 121: 290-7.
  • 3. Querleu D, Cibula D, Abu-Rustum NR. 2017 Update on the QuerleuMorrow Classification of Radical Hysterectomy. Ann Surg Oncol 2017; 24: 3406-12.
  • 4. Creasman WT, Zaino RJ, Major FJ, DiSaia PJ, Hatch KD, Homesley HD. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A gynecologic oncology group study. Am J Obstet Gynecol 1998; 178(1 Pt 1): 62-5.
  • 5. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95 Suppl 1: S43-103.
  • 6. Gadducci A, Sartori E, Maggino T, Landoni F, Zola P, Cosio S, et al. The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a cooperation task force (CTF) study. Eur J Gynaecol Oncol 2003; 24: 513-6.
  • 7. Ramirez PT, Pareja R, Rendon GJ, Millan C, Frumovitz M, Schmeler KM. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol 2014; 132: 254-9.
  • 8. Ayhan A, Tohma YA, Sahin H, Kocaman E, Tunc M, Haberal AN. Oncological and obstetric outcomes after fertility-sparing radical abdominal trachelectomy for early stage cervical cancer: a tertiary centre's 10 years' experience. J Obstet Gynaecol 2019; 39: 248-52.
  • 9. Potish RA, Twiggs LB, Okagaki T, Prem KA, Adcock LL. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging. Cancer 1985; 56: 956-60.
  • 10. Roman LD, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstet Gynecol 1997; 90: 759-64.
  • 11. Kinney WK, Hodge DO, Egorshin EV, Ballard DJ, Podratz KC. Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol 1995; 57: 3-6.
  • 12. Naik R, Cross P, Nayar A, Mayadevi S, Lopes A, Godfrey K, et al. Conservative surgical management of small-volume stage IB1 cervical cancer. BJOG 2007; 114: 958-63.
  • 13. Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer 2007; 110: 1281-6.
  • 14. Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Reis RD, Levenback CF, et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol 2009; 114: 93-9.
  • 15. Fagotti A, Gagliardi ML, Moruzzi C, Carone V, Scambia G, Fanfani F. Excisional cone as fertility-sparing treatment in early-stage cervical cancer. Fertil Steril 2011; 95: 1109-12.
  • 16. Palaia I, Musella A, Bellati F, Marchetti C, Di Donato V, Perniola G, et al. Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer. Gynecol Oncol 2012; 126: 78-81.
  • 17. Raju SK, Papadopoulos AJ, Montalto SA, Coutts M, Culora G, Kodampur M, et al. Fertility-sparing surgery for early cervical cancer-approach to less radical surgery. Int J Gynecol Cancer 2012; 22: 311-7.
  • 18. Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019; 145: 129-35.
  • 19. Dostalek L, Avall-Lundqvist E, Creutzberg CL, Kurdiani D, Ponce J, Dostalkova I, et al. ESGO survey on current practice in the management of cervical cancer. Int J Gynecol Cancer 2018; 28: 1226-31.
  • 20. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol 2002; 84: 145-9.
  • 21. Pluta M, Rob L, Charvat M, Chmel R, Halaska M Jr, Skapa P, et al. Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study. Gynecol Oncol 2009; 113: 181-4.
  • 22. Maneo A, Sideri M, Scambia G, Boveri S, Dell'anna T, Villa M, et al. Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. Gynecol Oncol 2011; 123: 557-60.
  • 23. Biliatis I, Kucukmetin A, Patel A, Ratnavelu N, Cross P, Chattopadhyay S, et al. Small volume stage 1B1 cervical cancer: Is radical surgery still necessary? Gynecol Oncol 2012; 126: 73-7.
  • 24. Plante M. A randomized trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low risk early stage cervical cancer. NCIC Clinical Trials Group. NCT016589309.ClinicalTrials.gov The SHAPE Trial; 2013.
  • 25. Schmeler K, Pareja R, Lopez A, Fregnani JH, Lopes A, Perrotta M, et al. 23 Concerv: a prospective trial of conservative surgery for lowrisk ea
APA Akilli H, Gunakan E, Kucukyildiz I, Tunç M, HABERAL REYHAN A, Ayhan A, Tohma Y (2021). Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. , 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
Chicago Akilli Huseyin,Gunakan Emre,Kucukyildiz Irem,Tunç Mehmet,HABERAL REYHAN ASUMAN NİHAN,Ayhan Ali,Tohma Yusuf Aytaç Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. (2021): 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
MLA Akilli Huseyin,Gunakan Emre,Kucukyildiz Irem,Tunç Mehmet,HABERAL REYHAN ASUMAN NİHAN,Ayhan Ali,Tohma Yusuf Aytaç Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. , 2021, ss.37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
AMA Akilli H,Gunakan E,Kucukyildiz I,Tunç M,HABERAL REYHAN A,Ayhan A,Tohma Y Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. . 2021; 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
Vancouver Akilli H,Gunakan E,Kucukyildiz I,Tunç M,HABERAL REYHAN A,Ayhan A,Tohma Y Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. . 2021; 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
IEEE Akilli H,Gunakan E,Kucukyildiz I,Tunç M,HABERAL REYHAN A,Ayhan A,Tohma Y "Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou." , ss.37 - 41, 2021. 10.4274/jtgga.galenos.2020.2020.0153
ISNAD Akilli, Huseyin vd. "Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou". (2021), 37-41. https://doi.org/10.4274/jtgga.galenos.2020.2020.0153
APA Akilli H, Gunakan E, Kucukyildiz I, Tunç M, HABERAL REYHAN A, Ayhan A, Tohma Y (2021). Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. Journal of the Turkish-German Gynecological Association, 22(1), 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
Chicago Akilli Huseyin,Gunakan Emre,Kucukyildiz Irem,Tunç Mehmet,HABERAL REYHAN ASUMAN NİHAN,Ayhan Ali,Tohma Yusuf Aytaç Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. Journal of the Turkish-German Gynecological Association 22, no.1 (2021): 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
MLA Akilli Huseyin,Gunakan Emre,Kucukyildiz Irem,Tunç Mehmet,HABERAL REYHAN ASUMAN NİHAN,Ayhan Ali,Tohma Yusuf Aytaç Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. Journal of the Turkish-German Gynecological Association, vol.22, no.1, 2021, ss.37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
AMA Akilli H,Gunakan E,Kucukyildiz I,Tunç M,HABERAL REYHAN A,Ayhan A,Tohma Y Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. Journal of the Turkish-German Gynecological Association. 2021; 22(1): 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
Vancouver Akilli H,Gunakan E,Kucukyildiz I,Tunç M,HABERAL REYHAN A,Ayhan A,Tohma Y Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou. Journal of the Turkish-German Gynecological Association. 2021; 22(1): 37 - 41. 10.4274/jtgga.galenos.2020.2020.0153
IEEE Akilli H,Gunakan E,Kucukyildiz I,Tunç M,HABERAL REYHAN A,Ayhan A,Tohma Y "Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou." Journal of the Turkish-German Gynecological Association, 22, ss.37 - 41, 2021. 10.4274/jtgga.galenos.2020.2020.0153
ISNAD Akilli, Huseyin vd. "Factors affecting parametrial involvement in cervicalcancer patients with tumor size ≤4 cm and selectionof low-risk patient grou". Journal of the Turkish-German Gynecological Association 22/1 (2021), 37-41. https://doi.org/10.4274/jtgga.galenos.2020.2020.0153